Shugo Kowata

Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial

Shinya Kimura, Jun Imagawa, Kazunori Murai et al. · The Lancet Haematology · 2020 · 100 citations

Hematological Malignancy, Medicine, First-line Dadi Trial +9

Absence of pseudomembranes in<i>Clostridium difficile</i>-associated diarrhea in patients using immunosuppression agents

Ken‐ichi Nomura, Yoshiko Fujimoto, Mihoko Yamashita et al. · Scandinavian Journal of Gastroenterology · 2008 · 75 citations

Platelet demand modulates the type of intravascular protrusion of megakaryocytes in bone marrow

Shugo Kowata, Sumio Isogai, Kazunori Murai et al. · Thrombosis and Haemostasis · 2014 · 45 citations

Biomedical Engineering, Cellular Physiology, Thrombosis +19

Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia

Shigeki Ito, Yoji Ishida, Tatsuo Oyake et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 43 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +17

Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes

Kazunori Murai, Shugo Kowata, Tadashi Shimoyama et al. · European Journal Of Haematology · 2014 · 24 citations